Mitochondrial DNA haplogroups and age at onset of schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 4, 2007, Pages 496-501

  Magri, Chiara ^a   Gardella, Rita ^a   Barlati, Stefano Davide ^b   Valsecchi, Paolo ^a,b   Sacchetti, Emilio ^a,b,c   Barlati, Sergio ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Brescia Spedali Civili ^*  (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Age at onset; Mitochondrial DNA; mt DNA levels; mt haplogroups; Schizophrenia

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; FEMALE; HAPLOTYPES; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; MALE; PHYLOGENY; SCHIZOPHRENIA;

EID: 34250860140     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30496     Document Type: Article

References (28)

1. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, Knable MB, Brockman JA. 2005. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58:85-96.
2. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association.
3. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. 1999. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147.
4. Cohen J. 1988. Statistical power analysis for the behavioral sciences, 2nd edition. Hillsdale, NJ: Erlbaum.
5. De Benedictis G, Rose G, Carrieri G, De Luca M, Falcone E, Passarino G, Bonafe M, Monti D, Baggio G, Bertolini S, Mari D, Mattace R, Franceschi C. 1999. Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 13:1532-15336.
6. Dror N, Klein E, Karry R, Sheinkman A, Kirsh Z, Mazor M, Tzukerman M, Ben-Shachar D. 2002. State-dependent alterations in mitochondrial complex I activity in platelets: A potential peripheral marker for schizophrenia. Mol Psychiatry 7:995-1001.
7. Faul F, Erdfelder E. 1992. GPOWER: A priori, post-hoc, and compromise power analyses for MS-DOS [Computer Program]. Bonn: Bonn University, Department of Psychology.
8. First MB, Spitzer RL, Gibbon M, Williams JBW. 1996. Structural Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-DV). Washington, DC: American Psychiatric Press.
9. Fukuzako H, Fukuzako T, Takeuchi K, Ohbo Y, Ueyama K, Takigawa M, Fujimoto T. 1996. Phosphorus magnetic resonance spectroscopy in schizophrenia: Correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Prog Neuropsychopharmacol Biol Psychiatry 20:629-640.
10. Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, Bonuccelli U, Petrozzi L, Abbruzzese G, Marchese R, Cortelli P, Grimaldi D, Martinelli P, Ferrarese C, Garavaglia B, Sangiorgi S, Carelli V, Torroni A, Albanese A, Zeviani M. 2005. Mitochondrial DNA hg K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet 13:748-752.
11. Iwamoto K, Bundo M, Kato T. 2005. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14:241-253.
12. Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, Manchanda R, Schaefer B, Densmore M, Drost DJ. 2006. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: (31)P-MRS chemical shift imaging at 4 Tesla. Psychiatry Res 146:127-135.
13. Kakiuchi C, Ishiwata M, Kametani M, Nelson C, Iwamoto K, Kato T. 2005. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol 8:512-522.
14. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276.
15. Kegeles LS, Humaran TJ, Mann JJ. 1998. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry 44:382-398.
16. Kung L, Roberts RC. 1999. Mitochondrial pathology in human schizophrenic striatum: A postmortem ultrastructural study. Synapse 31:67-75.
17. Magri C, Gardella R, Barlati SD, Podavini D, Iatropoulos P, Bonomi S, Valsecchi P, Sacchetti E, Barlati S. 2006. Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: A pilot case-control association study in an Italian sample. Am J Med Genet Part B 141B:287-293.
18. Martorell L, Segues T, Folch G, Valero J, Joven J, Labad A, Vilella E. 2006. New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet 14:520-528.
19. Maurer I, Zierz S, Moller H. 2001. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48:125-136.
20. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. 2002. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22:2718-2729.
21. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859.
22. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:36.
23. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S. 2004. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684-697, 643.
24. Prayson RA, Wang N. 1998. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome: An autopsy report. Arch Pathol Lab Med 122:978-981.
25. Prince JA, Blennow K, Gottfries CG, Karlsson I, Oreland L. 1999. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21:372-379.
26. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC. 2004. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303:223-226.
27. Suzuki T, Koizumi J, Shiraishi H, Ishikawa N, Ofuku K, Sasaki M, Hori T, Ohkoshi N, Anno I. 1990. Mitochondrial encephalopathy (MELAS) with mental disorder. CT, MRI, and SPECT findings. Neuroradiology 32:74-76.
28. Thomeer EC, Verhoeven WM, van de Vlasakker CJ, Klompenhouwer JL. 1998. Psychiatric symptoms in MELAS; a case report. J Neurol Neurosurg Psychiatry 64:692-693.